Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Haibel

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|April 30, 2013
Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trialH Haibel, C Fendler, J Listing, et al.
Clinical and Experimental Rheumatology|June 21, 2008
Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practiceH Haibel, I H Song, M Rudwaleit, et al.
Rheumatology (Oxford, England)|August 11, 2005
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximabJ Sieper, X Baraliakos, J Listing, et al.
Zeitschrift Fur Rheumatologie|November 2, 2004
[Measurement of quality of life in patients with active ankylosing spondylitis being treated with infliximab-a comparison of SF-36 and SF-12]H Haibel, M Niewerth, J Brandt, et al.
Rheumatology (Oxford, England)|July 12, 2007
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximabX Baraliakos, J Listing, J Brandt, et al.
Annals of the Rheumatic Diseases|March 3, 2007
Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytesX Baraliakos, J Listing, M Rudwaleit, et al.
Zeitschrift Fur Rheumatologie|July 31, 2019
[Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a routine data analysis]I Redeker, J Callhoff, F Hoffmann, et al.
Arthritis and Rheumatism|December 13, 2005
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging dataX Baraliakos, J Brandt, J Listing, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot studyI-H Song, F Heldmann, M Rudwaleit, et al.
Rheumatology (Oxford, England)|November 25, 2004
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitisJ Brandt, J Listing, H Haibel, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|April 30, 2013
Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trialH Haibel, C Fendler, J Listing, et al.
Clinical and Experimental Rheumatology|June 21, 2008
Multicenter open-label study with infliximab in active ankylosing spondylitis over 28 weeks in daily practiceH Haibel, I H Song, M Rudwaleit, et al.
Rheumatology (Oxford, England)|August 11, 2005
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximabJ Sieper, X Baraliakos, J Listing, et al.
Zeitschrift Fur Rheumatologie|November 2, 2004
[Measurement of quality of life in patients with active ankylosing spondylitis being treated with infliximab-a comparison of SF-36 and SF-12]H Haibel, M Niewerth, J Brandt, et al.
Rheumatology (Oxford, England)|July 12, 2007
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximabX Baraliakos, J Listing, J Brandt, et al.
Annals of the Rheumatic Diseases|March 3, 2007
Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytesX Baraliakos, J Listing, M Rudwaleit, et al.
Zeitschrift Fur Rheumatologie|July 31, 2019
[Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a routine data analysis]I Redeker, J Callhoff, F Hoffmann, et al.
Arthritis and Rheumatism|December 13, 2005
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging dataX Baraliakos, J Brandt, J Listing, et al.
Annals of the Rheumatic Diseases|March 19, 2011
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot studyI-H Song, F Heldmann, M Rudwaleit, et al.
Rheumatology (Oxford, England)|November 25, 2004
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitisJ Brandt, J Listing, H Haibel, et al.
Pageof 4